Dr. Stewart A. Weber

Gabriel Zada, MD, MS, FAANS, FACS, is Professor of Neurological Surgery, Otolaryngology, and Physiology & Neuroscience at the Keck School of Medicine of USC and an internationally recognized leader in brain, skull base, and pituitary tumor surgery. He serves as Vice Chair of Education and Residency Program Director, Surgical Director of the USC Brain Tumor Center, and Director of the USC Endoscopic Skull Base Surgery Program.Dr. Zada has performed more than 3,000 cranial operations, specializing in minimally invasive and endoscopic approaches for brain, pituitary, and skull base tumors. He completed fellowship training under Dr. Edward Laws at Harvard/Brigham and Women’s Hospital and advanced training under Dr. Paolo Cappabianca in Naples, Italy.An NIH-funded investigator, Dr. Zada has authored more than 400 peer-reviewed publications and 3 surgical textbooks. He is Editor of *Neurosurgical Focus* and President-Elect of the AANS/CNS Joint Section on Tumors. FindExpertMD ranks him the **#1 neurosurgeon in California for pituitary tumors, meningiomas, skull base neoplasms, and neuroendoscopy**. He has treated patients from around the world including Mexico, Guam, Hawaii, Europe. South America, and Canada. Dr. Zada is highly rated in 65 conditions, according to our data. His clinical expertise encompasses Pituitary Tumor, Hypothalamic Tumor, Brain Tumor, Endoscopic Transnasal Transsphenoidal Surgery, and Gamma Knife Radiosurgery. Dr. Zada is board certified in American Board Of Neurological Surgery. Dr. Zada is currently accepting new patients.

Dr. Tahseen Mozaffar is a board-certified UCI Health neurologist who specialize in neuromuscular disorders, including amyotrophic lateral sclerosis (ALS), myasthenia gravis, inflammatory myopathies, Pompe disease, muscle pathology and all types of muscular dystrophies.He serves as director of the UCI Health ALS & Neuromuscular Center, one of only six Muscular Dystrophy Association-designated centers in California.Mozaffar earned his medical degree at the Aga Khan University in Karachi, Pakistan, where he completed a rotating internship in internal medicine and general surgery. He completed a neurology residency at Barnes-Jewish Hospital in St. Louis, Mo., followed by a fellowship in neuromuscular disorders at Washington University, also in St. Louis.His research focus includes clinical and translational studies of neuromuscular disorders and he is the principal site investigator of more than a dozen clinical trials for myasthenia gravis, immune myopathies and rare and ultra-rare myopathies. He is also the lead UCI investigator for NeuroNEXT, a collaborative national effort to help streamline phase 2 clinical trials for brain disorders that is supported by the National Institute of Neurological Disorders and Stroke (NINDS).As an expert in rare and ultra-rare myopathies, he advises many pharmaceutical companies on clinical trial design and the identification of disease targets. He serves on a Pompe disease advisory board for Amicus Therapeutics and Spark Therapeutics, as well as on the data safety monitoring board for Acceleron and Sarepta Therapeutics. He also is a reviewer with the Emerging Technologies and Training in Neurosciences (ETTN) group for the National Institutes of Health (NIH). He has co-authored more than 175 peer-reviewed publications and has written or co-written more than a dozen book chapters and reviews.Mozaffar, who is also fluent in Hindi and Urdu, sees patients inIrvineandOrange. Dr. Mozaffar is highly rated in 31 conditions, according to our data. His clinical expertise encompasses Pompe Disease, Inclusion Body Myositis, Myositis, Limb-Girdle Muscular Dystrophy, and Thymectomy. Dr. Mozaffar is board certified in American Board Of Psychiatry And Neurology - Neurology.

Dr. Namita Goyal is a board-certified, fellowship-trained UCI Health neurologist who specializes in the diagnosis and treatment of neuromuscular disorders. She serves as co-director of theUCI Health ALS Neuromuscular Center, one of only six Muscular Dystrophy Association-designated centers in California.Her clinical interests include muscular dystrophies, muscle disease, myasthenia gravis, myositis, amyotrophic lateral sclerosis (ALS) and demyelinating neuropathies. Certified in electrodiagnostic medicine, she performs a number of procedures including adult and pediatric electromyogram (EMG), single-fiber EMG and muscle biopsies.Goyal received her medical degree from Ross University School of Medicine in Bridgetown, Barbados. She completed a residency in neurology at the University of Chicago Medical Center, followed by a fellowship in electromyography, clinical neurophysiology and neuromuscular disease at Harvard University’s Massachusetts General Hospital in Boston, where she subsequently served as a faculty member.Her research interests include ALS, myositis, muscular dystrophies, myopathies and myasthenia gravis. She is the lead site investigator for several clinical trials involving neuromuscular diseases, with a special focus on ALS and myositis, and directs neurology clinical trials for the UCI School of Medicine. She also is the author of several published articles on neuromuscular disorders and is a frequent guest speaker at national conferences.In addition to her clinical and research work, she is a mentor to neurology fellows and residents and serves as director of the Department of Neurology's neuromuscular medicine fellowship program.Goyal sees patients inIrvineandOrange. Dr. Goyal is highly rated in 19 conditions, according to our data. Her clinical expertise encompasses Inclusion Body Myositis, Amyotrophic Lateral Sclerosis (ALS or Lou Gehrig's Disease), Myositis, and Primary Lateral Sclerosis. Dr. Goyal is board certified in American Board Of Psychiatry And Neurology - Neurology and American Board Of Psychiatry And Neurology - Neuromuscular Medicine.